Patents by Inventor Richard Milon Dujmovic, Jr.
Richard Milon Dujmovic, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11083898Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: June 25, 2019Date of Patent: August 10, 2021Assignee: CARDIAC PACEMAKERS, INC.Inventors: Joseph M. Smith, Richard Milon Dujmovic, Jr.
-
Publication number: 20190329059Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: ApplicationFiled: June 25, 2019Publication date: October 31, 2019Applicant: CARDIAC PACEMAKERS, INC.Inventors: JOSEPH M. SMITH, RICHARD MILON DUJMOVIC, Jr.
-
Patent number: 10363428Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: May 11, 2018Date of Patent: July 30, 2019Assignee: CARDIAC PACEMAKERS, INC.Inventors: Joseph M. Smith, Richard Milon Dujmovic, Jr.
-
Publication number: 20180256909Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: ApplicationFiled: May 11, 2018Publication date: September 13, 2018Applicant: CARDIAC PACEMAKERS, INC.Inventors: Joseph M. Smith, Richard Milon Dujmovic, JR.
-
Patent number: 9993654Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: April 26, 2016Date of Patent: June 12, 2018Assignee: CARDIAC PACEMAKERS, INC.Inventors: Joseph M. Smith, Richard Milon Dujmovic, Jr.
-
Publication number: 20150190638Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: ApplicationFiled: March 5, 2015Publication date: July 9, 2015Applicant: CARDIAC PACEMAKERS, INC.Inventors: Joseph M. Smith, Richard Milon Dujmovic, JR.
-
Patent number: 9002467Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: October 9, 2014Date of Patent: April 7, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Joseph M. Smith, Richard Milon Dujmovic, Jr.
-
Publication number: 20150039041Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: ApplicationFiled: October 9, 2014Publication date: February 5, 2015Inventors: Joseph M. Smith, Richard Milon Dujmovic, JR.
-
Patent number: 8903500Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as a defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: January 27, 2014Date of Patent: December 2, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Joseph M. Smith, Richard Milon Dujmovic, Jr.
-
Patent number: 8886308Abstract: An atrial event and a ventricular event can be received, and an atrioventricular (AV) delay can be provided using information about the atrial and ventricular events. The AV delay can be increased after a first condition is satisfied to allow a heart to regain intrinsic control of ventricular activation, and changed after a second condition is satisfied to allow the heart to remain in intrinsic control of ventricular activation.Type: GrantFiled: February 22, 2012Date of Patent: November 11, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: David L. Perschbacher, Richard Milon Dujmovic, Jr., Gary T. Seim
-
Publication number: 20140142648Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as a defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: ApplicationFiled: January 27, 2014Publication date: May 22, 2014Applicant: Cardiac Pacemakers, Inc.Inventors: Joseph M. Smith, Richard Milon Dujmovic, JR.
-
Patent number: 8649859Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as a defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: October 29, 2012Date of Patent: February 11, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Joseph M. Smith, Richard Milon Dujmovic, Jr.
-
Patent number: 8391990Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as a defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: GrantFiled: May 18, 2005Date of Patent: March 5, 2013Assignee: Cardiac Pacemakers, Inc.Inventors: Joseph M. Smith, Richard Milon Dujmovic, Jr.
-
Publication number: 20130053908Abstract: This document discusses, among other things, a modular antitachyarrhythmia therapy system. In an example, a modular antitachyarrhythmia system includes at least two separate modules that coordinate delivery an antitachyarrhythmia therapy, such as a defibrillation therapy. In another example, a modular antitachyarrhythmia therapy system includes a sensing module, an analysis module, and a therapy module.Type: ApplicationFiled: October 29, 2012Publication date: February 28, 2013Inventors: Joseph M. Smith, Richard Milon Dujmovic, JR.
-
Publication number: 20120316614Abstract: A cardiac rhythm management (CRM) system includes a programming device that identifies the device type of an implantable medical device, selects a predetermined questioning sequence based on the device type, and interacts with a user through a user interface screen by conducting a question-and-answer session according to the predetermined questioning sequence. After displaying a question and receiving an answer to the question, the programming device sets one or more programmable parameter values and/or displays a follow-up question in response to the answer. The programming device also allows the user to enter one or more programmable parameter values directly during or after the question-and-answer session. The implantable medical device is programmed to operate in one or more operational modes based on at least the answers received from the user during the question-and-answer session and the parameter values entered by the user, if any.Type: ApplicationFiled: August 20, 2012Publication date: December 13, 2012Inventors: James O. Gilkerson, Richard Milon Dujmovic, JR.
-
Patent number: 8255053Abstract: A cardiac rhythm management (CRM) system includes a programming device that identifies the device type of an implantable medical device, selects a predetermined questioning sequence based on the device type, and interacts with a user through a user interface screen by conducting a question-and-answer session according to the predetermined questioning sequence. After displaying a question and receiving an answer to the question, the programming device sets one or more programmable parameter values and/or displays a follow-up question in response to the answer. The programming device also allows the user to enter one or more programmable parameter values directly during or after the question-and-answer session. The implantable medical device is programmed to operate in one or more operational modes based on at least the answers received from the user during the question-and-answer session and the parameter values entered by the user, if any.Type: GrantFiled: March 16, 2010Date of Patent: August 28, 2012Assignee: Cardiac Pacemakers, Inc.Inventors: James O. Gilkerson, Richard Milon Dujmovic, Jr.
-
Publication number: 20120150254Abstract: An atrial event and a ventricular event can be received, and an atrioventricular (AV) delay can be provided using information about the atrial and ventricular events. The AV delay can be increased after a first condition is satisfied to allow a heart to regain intrinsic control of ventricular activation, and changed after a second condition is satisfied to allow the heart to remain in intrinsic control of ventricular activation.Type: ApplicationFiled: February 22, 2012Publication date: June 14, 2012Inventors: David L. Perschbacher, Richard Milon Dujmovic, JR., Gary T. Seim
-
Patent number: 8036744Abstract: A cardiac rhythm management device predicts defibrillation thresholds without any need to apply defibrillation shocks or subjecting the patient to fibrillation. Intravascular defibrillation electrodes are implanted in a heart. By applying a small test energy, an electric field near one of the defibrillation electrodes is determined by measuring a voltage at a sensing electrode offset from the defibrillation electrode by a known distance. A desired minimum value of electric field at the heart periphery is established. A distance between a defibrillation electrodes and the heart periphery is measured, either fluoroscopically or by measuring a voltage at an electrode at or near the heart periphery. Using the measured electric field and the measured distance to the periphery of the heart, the defibrillation energy needed to obtain the desired electric field at the heart periphery is estimated. In an example, the device also includes a defibrillation shock circuit and a stimulation circuit.Type: GrantFiled: December 7, 2009Date of Patent: October 11, 2011Assignee: Cardiac Pacemakers, Inc.Inventors: Richard Milon Dujmovic, Jr., Phil Foshee, Richard Fogoros, Joseph M. Smith, Douglas R. Daum, Weimin Sun
-
Patent number: 7697993Abstract: A cardiac rhythm management (CRM) system includes a programming device that identifies the device type of an implantable medical device, selects a predetermined questioning sequence based on the device type, and interacts with a user through a user interface screen by conducting a question-and-answer session according to the predetermined questioning sequence. After displaying a question and receiving an answer to the question, the programming device sets one or more programmable parameter values and/or displays a follow-up question in response to the answer. The programming device also allows the user to enter one or more programmable parameter values directly during or after the question-and-answer session. The implantable medical device is programmed to operate in one or more operational modes based on at least the answers received from the user during the question-and-answer session and the parameter values entered by the user, if any.Type: GrantFiled: May 13, 2004Date of Patent: April 13, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: James O. Gilkerson, Richard Milon Dujmovic, Jr.
-
Publication number: 20100087884Abstract: A cardiac rhythm management device predicts defibrillation thresholds without any need to apply defibrillation shocks or subjecting the patient to fibrillation. Intravascular defibrillation electrodes are implanted in a heart. By applying a small test energy, an electric field near one of the defibrillation electrodes is determined by measuring a voltage at a sensing electrode offset from the defibrillation electrode by a known distance. A desired minimum value of electric field at the heart periphery is established. A distance between a defibrillation electrodes and the heart periphery is measured, either fluoroscopically or by measuring a voltage at an electrode at or near the heart periphery. Using the measured electric field and the measured distance to the periphery of the heart, the defibrillation energy needed to obtain the desired electric field at the heart periphery is estimated. In an example, the device also includes a defibrillation shock circuit and a stimulation circuit.Type: ApplicationFiled: December 7, 2009Publication date: April 8, 2010Inventors: Richard Milon Dujmovic, JR., Phil Foshee, Richard Fogoros, Joseph M. Smith, Douglas R. Daum, Weimin Sun